Isolation and Characterization of Elasnin, a New Human Granulocyte Elastase Inhibitor Produced by a Strain of Streptomyces

47Citations
Citations of this article
8Readers
Mendeley users who have this article in their library.

Abstract

Elasnin, a new human granulocyte elastase inhibitor, produced by the strain of KM-2753 designated as Streptomyces noboritoensis KM-2753 has been isolated from the fermentation broth by column chromatography on silica gel and neutral alumina. Elasnin is a neutral, colorless, and viscous oil ([formula omitted] nm (e, 7,760)) having a molecular formula of C24H40O4 (MW 392) as shown by its elemental analysis and mass spectrum. Elasnin markedly inhibits human granulocyte elastase, but it is almost inactive against pancreatic elastase, chymotrypsin, and trypsin. At 1.3 μg/ml (3.3×10-6 m), elasnin is 50% inhibitory to human elastase, but it causes 50% inhibition of pancreatic elastase at 30.1 μg/ml (76.8×10-6 m). © 1978, JAPAN ANTIBIOTICS RESEARCH ASSOCIATION. All rights reserved.

Cite

CITATION STYLE

APA

Ohno, H., Saheki, T., Awaya, J., Nakagawa, A., & Omura, S. (1978). Isolation and Characterization of Elasnin, a New Human Granulocyte Elastase Inhibitor Produced by a Strain of Streptomyces. The Journal of Antibiotics, 31(11), 1116–1123. https://doi.org/10.7164/antibiotics.31.1116

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free